Bone remodeling depends on the dynamic coupling between new bone formation by osteoblasts and old bone removal by osteoclasts. ALP, TRAP, Cathepsin K, and MMPs participate in the establishment of the mineralization environment, osteoclast maturation, collagen degradation, and matrix remodeling, respectively, and their changes correspond to different stages and functional states of bone metabolism.

Keywords: bone remodeling; alkaline phosphatase; TRAP; Cathepsin K; MMP9; MMP13; osteoclast; bone matrix

1 Enzymatic Reaction Systems in Bone Remodeling

1.1 Bone Formation and Bone Resorption

(1) Bone Formation Side

Osteoblasts synthesize organic bone matrix such as type I collagen and promote matrix mineralization through ALP, matrix vesicles, and the local Ca²⁺/Pi environment. This process consists continuously of cell differentiation, collagen-matrix maturation, and mineral deposition. ALP mainly functions during preparation for and initiation of mineralization rather than serving as the sole effector enzyme throughout the entire bone-formation process.

(2) Bone Resorption Side

Mature osteoclasts form sealing zones and acidic resorption compartments on the bone surface, first dissolving inorganic minerals such as hydroxyapatite and then using Cathepsin K and other proteolytic enzymes to remove organic components such as type I collagen. TRAP is closely associated with the mature osteoclast phenotype, whereas MMP systems participate in local ECM processing, collagen cleavage, and tissue remodeling.

1.2 Functional Positioning of Major Enzymes

(1) Mineralization-Environment Regulatory Enzyme

Tissue-nonspecific alkaline phosphatase (TNAP) mainly acts on the bone-formation side by regulating the PPi/Pi balance and relieving local anti-mineralization constraints, thereby creating conditions for hydroxyapatite crystal formation.

(2) Osteoclast Maturation-Related Enzyme

Tartrate-resistant acid phosphatase (TRAP) is highly expressed in mature osteoclasts and is an important enzymatic marker for evaluating osteoclast differentiation and maturation. However, an increase in TRAP alone does not demonstrate that extensive bone-matrix resorption has already occurred.

(3) Matrix-Degrading Enzymes

Cathepsin K directly performs efficient degradation of organic bone matrix, particularly type I collagen. MMP9, MMP13, and related enzymes participate in processing gelatin, denatured collagen, fibrillar collagen, and other ECM components. Differences in substrate spectrum, activation mode, and spatial reaction environment determine their functional division in bone remodeling.

Table 1 Functional Positioning of Major Enzymes in Bone Remodeling

2 ALP: Mineralization-Environment Regulatory Enzyme on the Osteogenic Side

2.1 TNAP and Establishment of the Mineralization Environment

(1) PPi Hydrolysis and Relief of Anti-Mineralization Effects

In bone-formation studies, ALP mainly refers to TNAP encoded by ALPL. Extracellular inorganic pyrophosphate (PPi) can restrict hydroxyapatite crystal formation and growth. TNAP hydrolyzes PPi and reduces local PPi concentrations, thereby relieving inhibition of mineralization and allowing osteogenic matrix to gradually acquire conditions favorable for mineral-crystal formation.

(2) Pi Supply and Matrix Mineralization

TNAP-mediated hydrolysis of phosphorylated substrates helps increase the local availability of inorganic phosphate (Pi), allowing Ca²⁺ and Pi to form mineral deposits within an appropriate organic-matrix environment. This function needs to coordinate with mature type I collagen matrix, matrix vesicles, and other phosphate-regulatory pathways, so ALP activity represents only one functional node within the mineralization system.

(3) Role in Matrix Vesicles

Matrix vesicles released by osteoblasts provide a local microenvironment for early mineral nucleation, and TNAP can be distributed on the cell surface and matrix-vesicle membrane. This spatial localization concentrates PPi hydrolysis and Pi generation at sites of mineralization initiation, after which newly formed mineral crystals extend into the surrounding collagen matrix and gradually form mature mineralized structures.

2.2 Indicator Positioning of ALP in Osteogenic Differentiation

(1) Early-to-Mid-Stage Osteogenic Phenotype

As osteoblasts transition from the proliferative stage to the matrix-maturation stage, ALPL expression and ALP activity usually increase markedly. ALP is therefore commonly used to determine whether cells have entered osteogenic differentiation and mineralization-preparation programs. Compared with terminal indicators such as calcium deposition, ALP is more suitable for reflecting establishment of the osteogenic program and formation of a mineralization-permissive environment.

(2) ALP Positivity and Mature Mineralization

A marked increase in ALP does not mean that mature mineralization has been completed. If ALP positivity is pronounced while subsequent Alizarin Red S staining, calcium content, or mineralized nodules remain low, a more appropriate interpretation is that the cells have entered the osteogenic stage but matrix maturation or terminal mineral deposition remains insufficient.

2.3 ALP In Situ Staining and BCIP/NBT

BCIP/NBT converts ALP activity into localized insoluble colored precipitates. ALP dephosphorylates BCIP to generate a reaction intermediate, which couples with NBT-related redox reactions and ultimately produces blue to blue-violet precipitates, allowing spatial visualization of enzymatic activity. This method is suitable for observing ALP-positive regions and spatial heterogeneity within osteoblast populations, but color intensity is simultaneously affected by cell number, staining time, and local enzyme activity. It therefore mainly provides localization and semiquantitative information; overall ALP activity and mature mineralization still need to be evaluated using independent enzyme-activity and late-stage mineralization indicators.

3 TRAP: Acid Phosphatase Associated with Osteoclast Maturation

3.1 Enzymatic Characteristics of ACP5

(1) Metallo-Acid Phosphatase

TRAP is mainly encoded by ACP5 and belongs to the family of metallo-acid phosphatases, with relatively high catalytic activity in acidic environments. ACP5 is highly expressed in mature osteoclasts, making TRAP a representative enzymatic characteristic of the osteoclast lineage.

(2) Tartrate Resistance

An important experimental characteristic of TRAP is that its phosphatase activity is relatively resistant to tartrate, whereas some other acid phosphatases are markedly inhibited under the same conditions. This difference improves the specificity of TRAP enzyme histochemistry and makes it suitable for osteoclast-related evaluation.

3.2 Position of TRAP in Osteoclast Differentiation

(1) RANKL–NFATc1 Induction

After osteoclast precursors receive differentiation signals such as RANKL, they gradually establish an osteoclast transcriptional program centered on NFATc1, accompanied by increased expression of characteristic genes including ACP5, CTSK, DCSTAMP, and ATP6V0D2. TRAP therefore lies at the downstream phenotypic level of the osteoclast-differentiation program rather than functioning as an upstream initiating signal.

(2) TRAP-Positive Multinucleated Cells

Mature osteoclasts are formed through fusion of mononuclear precursors, so in vitro induction studies usually assess both TRAP positivity and the degree of multinucleation. An increase in individual TRAP-positive cells indicates enhancement of the osteoclast-differentiation program, whereas formation of large TRAP-positive multinucleated cells more closely reflects the mature osteoclast phenotype.

(3) TRAP and Terminal Bone Resorption

TRAP positivity does not directly prove that mature cells possess strong bone-resorptive capacity. A more complete evaluation requires assessment of F-actin rings, sealing zones, resorption pits, local acidification, Cathepsin K, and other indicators to distinguish osteoclast formation from actual efficient bone-matrix degradation.

4 Cathepsin K: Core Protease for Bone Collagen Degradation

4.1 Bone-Resorption Environment of Cathepsin K

(1) High Expression in Osteoclasts

Cathepsin K is encoded by CTSK and belongs to the cysteine cathepsin family. It is highly expressed in mature osteoclasts. Compared with TRAP, which is mainly used to identify the mature osteoclast phenotype, Cathepsin K more directly participates in actual proteolysis of organic bone matrix and therefore represents an important enzyme at the execution stage of bone resorption.

(2) Acidic Resorption Compartment

After osteoclasts adhere to the bone surface, they form a sealing zone and establish a low-pH resorption compartment through proton transport. Acidification first promotes dissolution of mineral components such as hydroxyapatite and simultaneously provides an appropriate proteolytic environment for Cathepsin K, allowing exposed collagen and other matrix proteins to be further degraded.

4.2 Cathepsin K and Collagen Degradation

(1) Type I Collagen Hydrolysis

Type I collagen constitutes the major component of the organic bone matrix and forms stable triple-helical structures and collagen fibrils. Cathepsin K has strong collagenolytic activity and can act on mature type I collagen and other bone-matrix proteins, making its function more directly related to osteoclastic matrix removal than general lysosomal protein turnover.

(2) CTSK and Actual Bone Resorption

Increased CTSK expression indicates enhancement of the osteoclast collagen-degradation program but cannot independently be equated with increased resorption area. Enzyme maturation, vesicular trafficking, local acidification, cell polarization, and sealing-zone formation all affect final function. CTSK should therefore be evaluated together with bone-slice resorption pits or collagen-degradation-related indicators.

4.3 Experimental Significance of Cathepsin K Inhibition

Pharmacological inhibition of Cathepsin K can reduce organic bone-matrix degradation without completely blocking osteoclast formation, making it suitable for distinguishing osteoclast maturation from bone-resorption execution. If TRAP-positive multinucleated cells remain present after inhibition while resorption pits or collagen degradation are markedly reduced, this supports the positioning of CTSK primarily at the terminal matrix-degradation execution level.

5 MMPs: Proteolytic Systems in Bone-Matrix Remodeling

5.1 MMP9

(1) Osteoclast Migration and Matrix Opening

MMP9 belongs to the gelatinase class of matrix metalloproteinases and can participate in local ECM remodeling in both osteoclast precursors and mature osteoclasts. By modifying matrix barriers surrounding cells, MMP9 can influence cell migration, tissue recruitment, and establishment of resorption regions, so its function is not limited to direct degradation of mature bone collagen.

(2) Degradation of Gelatin and Denatured Collagen

MMP9 efficiently hydrolyzes gelatin, denatured collagen, and multiple ECM proteins. Unlike Cathepsin K, which performs efficient collagen degradation within the acidic resorption compartment, MMP9 is more oriented toward extracellular matrix processing and tissue remodeling. Its increase therefore cannot independently serve as evidence of enhanced bone resorption.

5.2 MMP13

(1) Cleavage of Fibrillar Collagen

MMP13 is a collagenase capable of cleaving fibrillar collagen, converting intact collagen molecules into fragments that are more readily processed by other proteases. It therefore plays an important role in collagen-network turnover, bone-matrix remodeling, and pathological matrix destruction.

(2) Bone and Cartilage Matrix Remodeling

MMP13 is not an osteoclast-specific enzyme. Osteoblasts, chondrocytes, and certain inflammatory or pathological tissue cells can all express it. In bone-joint or bone-remodeling studies, increased MMP13 may simultaneously reflect bone-matrix remodeling, cartilage collagen degradation, or inflammation-related ECM destruction and therefore needs to be interpreted in conjunction with tissue source and other bone-resorption indicators.

5.3 Functional Differences Between MMPs and Cathepsin K

Cathepsin K is more concentrated within the acidic resorption compartment established by osteoclasts and uses mature type I collagen as an important substrate. MMP9 and MMP13 mainly participate in cleavage of collagen in different states and other ECM components within the extracellular matrix environment. All three enzyme classes can participate in bone-matrix turnover, but their spatial localization, substrate selection, activation mechanisms, and optimal reaction environments differ.

Table 2 Functional Differences Among Bone Resorption-Related Proteolytic Enzymes

6 Functional Coordination Between Osteogenic and Bone-Resorption Enzyme Systems

6.1 Bone Formation Side

Osteoblasts first generate organic matrix such as type I collagen, after which ALP increases and alters the local PPi/Pi balance, enabling the newly formed matrix to support mineral deposition. As the matrix matures, Ca²⁺ and Pi gradually form mineralized structures. ALP should therefore be analyzed on a continuous time axis together with collagen formation and late-stage mineralization indicators.

6.2 Bone Resorption Side

After osteoclast precursors complete differentiation and fusion, they form TRAP-positive multinucleated cells and establish F-actin rings, sealing zones, and acidification machinery. Cathepsin K subsequently performs degradation of bone collagen and other organic matrix components, while MMP systems further participate in processing the surrounding ECM, forming a continuous functional chain from osteoclast differentiation to establishment of the resorption apparatus and matrix degradation.

6.3 Osteoblast–Osteoclast Coupling

Changes in bone mass ultimately depend on the relative rates of formation and resorption rather than on the increase or decrease of any single enzyme. Simultaneous increases in ALP and TRAP may indicate accelerated overall bone turnover. A decrease in CTSK can reduce bone-collagen degradation, but it cannot be used to infer that osteogenic mineralization necessarily increases. Experimental designs therefore need separate indicators for the bone-formation and bone-resorption sides.

7 Experimental Research and Result Interpretation

7.1 Osteogenic-Side Interpretation

(1) ALP Phenotype

Increased ALP activity or BCIP/NBT-positive areas can support establishment of the osteogenic differentiation program but need to be interpreted in relation to cell number and induction time. If marked ALP staining occurs without corresponding formation of mineralized nodules, the result is more appropriately classified as an early- or mid-stage osteogenic phenotype rather than mature bone formation.

(2) Mature Mineralization

Late-stage mineralization is more appropriately evaluated using Alizarin Red S staining, calcium content, and mineralized nodules. ALP and these indicators occupy different temporal levels, and combined analysis can distinguish entry into the osteogenic program from completion of substantial mineral deposition.

7.2 Osteoclast-Side Interpretation

(1) TRAP

TRAP is mainly used to evaluate osteoclast differentiation and maturation phenotypes and should be assessed together with the number of positive cells and the degree of multinucleation. Increased TRAP without an obvious increase in resorption pits is more appropriately interpreted as increased osteoclast formation rather than necessarily enhanced terminal bone-resorption function.

(2) Cathepsin K

CTSK is closer to the bone-matrix degradation execution level and can be used to assess whether mature osteoclasts have established a strong proteolytic program. If CTSK is inhibited while TRAP-positive multinucleated cells remain present, this may indicate separation between osteoclast formation and matrix-degradation function.

(3) Bone Resorption Pits

Resorption pits on bone slices or mineralized matrices directly reflect the ability of cells to remove matrix and therefore occupy a higher functional level than TRAP, CTSK, or MMP expression alone. In experiments intended to demonstrate enhanced bone resorption, resorbed area is an important terminal functional indicator.

7.3 Enzyme Expression and Actual Activity

(1) MMP Activation State

MMPs are usually synthesized as proenzymes, so increased protein expression does not mean that active enzyme levels increase proportionally. Studies of MMP9- or MMP13-mediated matrix degradation need to incorporate activity assays, substrate cleavage, or inhibitor intervention rather than attributing effects solely on the basis of total protein levels.

(2) Cathepsin K Reaction Environment

Actual collagen-degrading capacity of Cathepsin K depends on enzyme maturation and the acidic resorption environment. Even when CTSK protein levels are high, final bone-matrix degradation can still be markedly limited if osteoclasts cannot properly establish sealing zones or maintain resorption-compartment acidification.

8 Bone Remodeling-Related Enzymes and Detection Products

8.1 ALP/TNAP and Osteogenic Phenotype-Related Products

8.2 TRAP- and Cathepsin K-Related Osteoclast Functional Products

8.3 MMP9, MMP13, and Bone-Matrix Remodeling-Related Products

Different enzymes involved in bone remodeling correspond to distinct functional stages including establishment of the mineralization environment, osteoclast maturation, and matrix degradation. ALP, TRAP, Cathepsin K, and MMP9/MMP13 need to be analyzed together with spatial localization, direct substrates, enzyme activity status, and terminal functional indicators in order to distinguish changes in bone formation, osteoclast differentiation, and actual bone resorption.

For more related articles, please see below:

[1] Standard Operating Procedure for Osteogenic Differentiation of Mesenchymal Stem Cells and Evaluation by ALP and Alizarin Red S Staining

[2] Protocol for Osteoblast Mineralization on β-Tricalcium Phosphate Scaffolds and Quantitative Alizarin Red S Assay

[3] A nude mouse model of human osteogenic sarcoma

[4] Rat Mammalian Osteoblast Culture Experiment

[5] Osteoblast primary culture experiment

[6] Mechanisms and Experimental Applications of β-GP, Ascorbic Acid, and Dexamethasone in Osteogenic Induction Systems